Acceleron Pharma (XLRN) was a big mover last session, as its shares rose almost 13% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Aug 28, as the stock is now trading above the volatile price range of $24.21 to $27.45.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Acceleron Pharma currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Other well-performing stocks in the biomedical/gene industry include Gilead Sciences Inc. (GILD), Cambrex Corporation. (CBM) and China Biologic Products, Inc. (CBPO). While Cambrex Corp. and Gilead Sciences sport a Zacks Rank #1 (Strong Buy), China Biologic Products carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment